The National Center for Regenerative Medicine supports investigators conducting innovative research translating into cell-based therapies and technologies.
NCRM’s comprehensive "bench-to-bedside" approach requires partnering with researchers and institutions to support programs in the areas of:
- Basic research
- Clinical research
- Biomedical/tissue engineering research
Using stem cells to regenerate new tissue in diseased organs, instead of using drugs or devices, represents a new paradigm in biomedical research. NCRM’s collaborative partnerships have advanced research discoveries and therapeutic uses of stem cells for the following:
- Cardiovascular disease
- Adult stem cell transplantation
- Cancer
- Genetic disorders
- Musculoskeletal conditions
- Neurodegenerative conditions
Our non-embryonic stem investigation uses the following cell types:
- ASC (adipose stem cells)
- CSC (cochlear stem cells)
- CTP (connective tissue progenitors)
- HSC (hematopoietic stem cells)
- HB1 (hemangioblast AC133+ cells from umbilical cord blood)
- MSC (mesenchymal stem cells)
- MAPC (multipotent adult progenitor cells)
- NSC (neural stem cells/oligodendrocyte progenitors)
- SKMB (skeletal myoblasts)
- UCB (umbilical cord blood-derived stem cells)